Unveiling the Hidden Impact: How Hip Involvement Signals Severe Axial Spondyloarthritis
Uncover the Surprising Connection
Did you know that hip involvement is a critical indicator of severe axial spondyloarthritis? In a recent study, researchers from a rheumatology outpatient clinic in Rabat, Morocco, discovered a strong link between hip involvement and greater overall severity in axial spondyloarthritis patients. But here's where it gets controversial: the study also found that the prevalence of hip involvement in this outpatient cohort was lower than figures commonly reported from university hospital series.
Understanding Hip Involvement
Hip involvement is a recognized extraspinal manifestation of axial spondyloarthritis, which can lead to poorer functional outcomes. In this study, researchers evaluated confirmed ankylosing spondylitis patients followed between 2019 and 2023 to better define how often hip disease appears in routine outpatient care and how it relates to symptomatic and structural severity.
Hip involvement was defined as hip pain attributed to inflammatory disease activity and supported by radiographic findings, using a Bath Ankylosing Spondylitis Radiology Hip Index (BASRI) score of at least 2. Among 137 patients, radiographic hip involvement was identified in 19 patients, with involvement being unilateral in nine patients and bilateral in 10, reinforcing that hip involvement may present on one side or affect both hips.
Who Was Most Likely to Have Hip Involvement?
The analysis found that hip involvement was more common in men and in patients with longer disease duration. The study also found a higher incidence of uveitis among those with hip involvement, suggesting clustering of more severe clinical features in this subgroup. Using Kaplan Meier estimates, the risk of hip involvement rose over time, with 18.6% of male patients affected after 10 years of disease duration and 48.8% after 20 years.
Association With Higher Disease Activity and Damage
Patients with hip involvement had higher symptomatic severity scores, including Bath Ankylosing Spondylitis Disease Activity Index and Ankylosing Spondylitis Disease Activity Score, alongside greater structural burden as reflected by higher modified Stoke Ankylosing Spondylitis Spine Score values. The authors concluded that hip involvement is a frequent manifestation linked to longer disease duration and greater disease severity.
What's Next?
This study highlights the importance of monitoring hip involvement in axial spondyloarthritis patients, as it can be a critical indicator of disease severity. However, the lower prevalence of hip involvement in this outpatient cohort compared to university hospital series raises questions about the factors influencing the manifestation and severity of hip involvement. Further research is needed to explore these factors and develop targeted interventions to improve patient outcomes.
